Thrombocytopenia
MONDO:0002049A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.
Also known as: platelet count decreased, thrombocytopenic disorder
266 clinical trials for this condition and its sub-types, 74 tagged with Thrombocytopenia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytopenia
-
Thrombocytopenic purpura 8 trials · 116 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types Sub-types →
-
Autoimmune thrombocytopenia 8 trials · 113 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Evans syndrome 19 trials
-
Inherited thrombocytopenia 2 trials · 29 incl. sub-types
21 sub-types
- Thrombocytopenia 1 9 trials
- Syndromic constitutional thrombocytopenia 0 trials · 8 incl. sub-types Sub-types →
- Congenital amegakaryocytic thrombocytopenia 4 trials · 6 incl. sub-types Sub-types →
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Alpha granule disease 0 trials Sub-types →
- Autosomal dominant macrothrombocytopenia 0 trials Sub-types →
- Congenital autosomal recessive small-platelet thrombocytopenia 0 trials
- Isolated delta-storage pool disease 0 trials
- Macrothrombocytopenia, isolated 0 trials Sub-types →
- Thrombocytopenia 10 0 trials
- Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0 trials
- Thrombocytopenia 12 with or without myopathy 0 trials
- Thrombocytopenia 13, syndromic 0 trials
- Thrombocytopenia 2 0 trials
- Thrombocytopenia 3 0 trials
- Thrombocytopenia 4 0 trials
- Thrombocytopenia 5 0 trials
- Thrombocytopenia 7 0 trials
- Thrombocytopenia 9 0 trials
- Thrombocytopenia, X-linked, with or without dyserythropoietic anemia 0 trials Sub-types →
- Thrombocytopenia, cyclic 0 trials
-
Acquired thrombocytopenia 11 trials · 24 incl. sub-types
1 sub-type
-
Neonatal thrombocytopenia 5 trials
1 sub-type
- Transient neonatal thrombocytopenia 0 trials
Most studied deeper sub-types
-
A diet tweak may boost platelets in a bleeding disorder
Disease control Not yet recruitingThis trial tests whether adding a selective Mediterranean diet to standard treatment can improve platelet counts and reduce bleeding in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. Sixty adults aged 18 to 60 with low platelet c…
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a bispecific antibody tame two autoimmune blood disorders?
Disease control Not yet recruitingThis trial is testing an investigational drug called velinotamig in adults with immune thrombocytopenia (ITP) or warm autoimmune hemolytic anemia (wAIHA) that has relapsed or not responded to standard treatments. Velinotamig is an engineered bispecific antibody designed to target…
Phase 1/2 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Cord blood cells aim to speed platelet recovery in transplant patients
Disease control Not yet recruitingThis early study tests an experimental cell therapy called MegaLT, made from umbilical cord blood cells, to help restore platelet levels faster after a cord blood transplant. Adults with blood cancers who receive a cord blood transplant will get a single infusion of MegaLT two we…
Early phase 1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug aims to keep platelets up during breast cancer chemo
Disease control Not yet recruitingThis phase 2 study tests whether the drug hetrombopag can prevent dangerously low platelet counts caused by chemotherapy in breast cancer patients at high risk. About 126 participants will be split into three groups: one getting no preventive drug, one taking hetrombopag continuo…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to shrink spleen in Hard-to-Treat myelofibrosis
Disease control Not yet recruitingThis phase II trial tests two oral drugs, selinexor and pacritinib, in 26 adults with myelofibrosis who have anemia and low platelets and have not taken JAK inhibitors before. The main goal is to see if the combination can shrink the spleen by at least 35%. The study also tracks …
Phase 2 • Sponsor: John Mascarenhas • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug aims to prevent dangerous platelet drop in breast cancer patients
Disease control Not yet recruitingThis study tests a drug called hetrombopag to see if it can prevent or reduce low platelet counts caused by antibody-drug conjugate (ADC) chemotherapy in breast cancer patients. The trial will include 72 adults aged 18-75. Researchers will measure how many patients develop severe…
Phase 2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug aims to fix Chemo-Induced low platelets
Disease control Not yet recruitingThis study tests a drug called Romiplostim N01 in 106 cancer patients whose platelets drop due to chemo, radiation, or immunotherapy. The goal is to see if it can safely raise platelet counts better than the current standard treatment. Patients will be randomly assigned to receiv…
Sponsor: Jun wang • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
ITP showdown: daily pill vs IV infusion in major new trial
Disease control Not yet recruitingThis phase 3 trial will compare two second-line treatments for immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risk. About 220 adults who didn't respond to steroids will be randomly assigned to take avatrombopag (a daily pil…
Phase 3 • Sponsor: Ostfold Hospital Trust • Aim: Disease control
Last updated Jun 26, 2026 14:30 UTC
-
Platelet transfusions may influence blood vessel health in critically ill patients
Knowledge-focused Not yet recruitingThis study investigates how platelet transfusions affect the function of small blood vessels and inflammation in intensive care patients with low platelet counts. Researchers measure blood vessel response using a laser device on the skin and track levels of various biomarkers in …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Blood test could predict bleeding risk in cancer patients
Knowledge-focused Not yet recruitingThis study aims to create a score that uses a special blood test to predict bleeding risk in people with blood cancers and very low platelet counts. Researchers will take an extra blood sample from 410 participants and analyze it with viscoelastometric tests. The goal is to ident…
Sponsor: Centre Hospitalier Annecy Genevois • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC